SCHEMBL5675155

SCHEMBL5675155

CN(C)CCOc1ccc2c(c1)CC[C@@H]1[C@H]3CCC(=O)[C@]3(C)CC[C@@H]21

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.71
ALDH1A1 P00352 1/20 0.71
HSD17B1 P14061 3/20 0.70
LMNA P02545 2/20 0.70
MAPT P10636 2/20 0.70
RECQL P46063 1/20 0.70
SMN1; SMN2 Q16637 1/20 0.70
STS P08842 10/20 0.68
CA1 P00915 3/20 0.68
CA2 P00918 3/20 0.68
CA9 Q16790 3/20 0.68
ESR1 P03372 2/20 0.68
ESR2 Q92731 2/20 0.68
CA4 P22748 1/20 0.68
CA6 P23280 1/20 0.68
ABCC4 O15439 1/20 0.66
CYP2C9 P11712 1/20 0.66
ABCC1 P33527 1/20 0.66
SLCO1B1 Q9Y6L6 1/20 0.66
CYP3A4 P08684 3/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8153062 1.00 KDM4E (0.71) KDM4EALDH1A1HSD17B1LMNAMAPT
SCHEMBL8145682 1.00 KDM4E (0.71) KDM4EALDH1A1HSD17B1LMNAMAPT
SCHEMBL8152986 0.95 KDM4E (0.69) KDM4EALDH1A1HSD17B1LMNAMAPT
SCHEMBL8144769 0.94 KDM4E (0.68) KDM4EALDH1A1HSD17B1LMNAMAPT
SCHEMBL8153960 0.93 KDM4E (0.67) KDM4EALDH1A1HSD17B1LMNAMAPT
SCHEMBL8152475 0.93 KDM4E (0.67) KDM4EALDH1A1HSD17B1LMNAMAPT
SCHEMBL5676213 0.90 KDM4E (0.68) KDM4EALDH1A1HSD17B1LMNAMAPT
SCHEMBL8144721 0.90 KDM4E (0.68) KDM4EALDH1A1HSD17B1LMNAMAPT
SCHEMBL8153756 0.90 KDM4E (0.68) KDM4EALDH1A1HSD17B1LMNAMAPT
SCHEMBL14044784 0.89 HSD17B1 (0.74) KDM4EALDH1A1HSD17B1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1169336-B1 ENT-STEROIDS AS SELECTIVELY ACTIVE ESTROGENS SCHERING AG (DE) 2006-02-01 EP claimed
EP-0676202-B1 Use of aromatic steroids substituted in 3-position by a disubstituted aminoalkoxy chain for the manufacture of a medicament for the control of fertility, in particular male fertility HOECHST MARION ROUSSEL INC (FR) 2000-06-07 EP claimed
EP-1169336-B1 ENT-STEROIDS AS SELECTIVELY ACTIVE ESTROGENS SCHERING AG (DE) 2006-02-01 EP disclosed
EP-0676202-B1 Use of aromatic steroids substituted in 3-position by a disubstituted aminoalkoxy chain for the manufacture of a medicament for the control of fertility, in particular male fertility HOECHST MARION ROUSSEL INC (FR) 2000-06-07 EP disclosed
EP-0676202-A2 Use of aromatic steroids substituted in 3-position by a disubstituted aminoalkoxy chain for the manufacture of a medicament for the control of fertility, in particular male fertility ROUSSEL UCLAF (FR) 1995-10-11 EP disclosed